Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN GLARGINE for Latent autoimmune diabetes in adults: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 110 adverse event reports in the FDA FAERS database where INSULIN GLARGINE was used for Latent autoimmune diabetes in adults.

Most Reported Side Effects for INSULIN GLARGINE

Side Effect Reports % Deaths Hosp.
Blood glucose increased 19,234 19.3% 78 2,476
Inappropriate schedule of product administration 8,982 9.0% 32 518
Product storage error 7,743 7.8% 12 323
Off label use 6,842 6.9% 21 317
Visual impairment 5,793 5.8% 17 380
Blood glucose decreased 4,552 4.6% 24 702
Drug ineffective 4,351 4.4% 55 417
Hypoglycaemia 4,212 4.2% 135 2,017
Injection site pain 3,574 3.6% 4 147
Device issue 3,175 3.2% 3 144
Incorrect dose administered 3,070 3.1% 10 207
Product use issue 3,042 3.1% 12 335
Glycosylated haemoglobin increased 2,649 2.7% 22 459
Blood glucose abnormal 2,463 2.5% 23 350
Malaise 2,458 2.5% 29 593

Other Indications for INSULIN GLARGINE

Type 2 diabetes mellitus (41,731) Diabetes mellitus (19,253) Product used for unknown indication (15,021) Type 1 diabetes mellitus (6,569) Blood glucose increased (2,765) Hyperglycaemia (198) Insulin-requiring type 2 diabetes mellitus (180) Gestational diabetes (148) Blood glucose abnormal (86) Diabetes mellitus management (74)

Other Drugs Used for Latent autoimmune diabetes in adults

INSULIN LISPRO (119) EMPAGLIFLOZIN (50) INSULIN ASPART (48) INSULIN DEGLUDEC (37) INSULIN HUMAN (33) DULAGLUTIDE (24) CANAGLIFLOZIN (21) DAPAGLIFLOZIN (18) INSULIN DETEMIR (18) METFORMIN (16)

Related Pages

INSULIN GLARGINE Full Profile All Latent autoimmune diabetes in adults Drugs INSULIN GLARGINE Demographics INSULIN GLARGINE Timeline